We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+18.99%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$3.18B
AUM Growth
+$505M
Cap. Flow
+$202M
Cap. Flow %
6.35%
Top 10 Hldgs %
63.18%
Holding
711
New
199
Increased
99
Reduced
149
Closed
234

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$182M
2
TSLA icon
Tesla
TSLA
+$107M
3
CNC icon
Centene
CNC
+$68.7M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$55.4M
5
ISRG icon
Intuitive Surgical
ISRG
+$52.1M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$36.8M
2
CTLT
CATALENT, INC.
CTLT
+$31.8M
3
PYPL icon
PayPal
PYPL
+$20.3M
4
MSFT icon
Microsoft
MSFT
+$10.9M
5
SWN
Southwestern Energy Company
SWN
+$10.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 46.05%
2 Technology 20.45%
3 Healthcare 7.37%
4 Financials 6.61%
5 Communication Services 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CIM
326
Chimera Investment
CIM
$1.05B
$510K 0.02%
36,455
-18,701
-34% -$280K
XYZ
327
Block Inc
XYZ
$46.1B
$504K 0.02%
+5,934
New +$487K
TPL icon
328
Texas Pacific Land
TPL
$29.9B
$504K 0.02%
+1,368
New +$559K
MTD icon
329
Mettler-Toledo International
MTD
$26B
$504K 0.02%
+412
New +$538K
TGTX icon
330
TG Therapeutics
TGTX
$8.06B
$498K 0.02%
16,557
– –
DDD icon
331
3D Systems Corp
DDD
$434M
$498K 0.02%
151,780
– –
UTHR icon
332
United Therapeutics
UTHR
$26.2B
$495K 0.02%
1,402
-3,284
-70% -$1.21M
FINV
333
FinVolution Group
FINV
$1.13B
$493K 0.02%
72,561
-41,903
-37% -$270K
KD icon
334
Kyndryl
KD
$2.57B
$492K 0.02%
+14,226
New +$414K
ZUMZ icon
335
Zumiez
ZUMZ
$319M
$486K 0.02%
25,368
-10,559
-29% -$225K
SMH icon
336
VanEck Semiconductor ETF
SMH
$70.7B
$486K 0.02%
+2,006
New +$498K
ALGN icon
337
Align Technology
ALGN
$12.4B
$486K 0.02%
+2,329
New +$520K
AMGN icon
338
Amgen
AMGN
$198B
$483K 0.02%
1,854
-3,820
-67% -$1.13M
VRT icon
339
Vertiv
VRT
$116B
$483K 0.02%
+4,247
New +$504K
EHC icon
340
Encompass Health
EHC
$11B
$480K 0.02%
5,203
+336
+7% +$33K
KRC icon
341
Kilroy Realty
KRC
$4.49B
$478K 0.02%
11,829
-28,156
-70% -$1.14M
RERE
342
ATRenew
RERE
$848M
$473K 0.01%
+164,358
New +$457K
EZPW icon
343
Ezcorp Inc
EZPW
$2B
$472K 0.01%
+38,611
New +$458K
SEIC icon
344
SEI Investments
SEIC
$11.9B
$469K 0.01%
+5,686
New +$446K
LMND icon
345
Lemonade
LMND
$4.87B
$467K 0.01%
12,743
– –
TDAY
346
USA Today Co
TDAY
$1.25B
$466K 0.01%
92,191
+13,707
+17% +$72.8K
OPTU
347
Optimum Communications Inc
OPTU
$350M
$466K 0.01%
193,321
+165,943
+606% +$414K
PRIM icon
348
Primoris Services
PRIM
$4.86B
$464K 0.01%
+6,073
New +$444K
HIG icon
349
Hartford Financial Services
HIG
$38.6B
$463K 0.01%
+4,236
New +$491K
REGN icon
350
Regeneron Pharmaceuticals
REGN
$68.3B
$454K 0.01%
637
+49
+8% +$41.1K
12 13
14
15 16

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q4 2024 Portfolio in Review

As of Q4 2024, Caxton Associates (New York) held 711 positions worth $3.18B, up 19% from $2.67B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Caxton Associates (New York) deployed $202M of net new capital in Q4 2024, opening 199 new positions and adding to 99 existing holdings. Its largest new stake was Centene: 1,101,163 shares worth $66.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 46% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $36.8M trimmed.

  • Caxton Associates (New York)'s largest Q4 2024 buy was Centene: 1,101,163 shares worth $66.7M.
  • Caxton Associates (New York) added most to Amazon in Q4 2024, an estimated $182M increase.
  • Caxton Associates (New York)'s biggest Q4 2024 reduction was Meta Platforms (Facebook), cutting an estimated $36.8M.
  • Caxton Associates (New York) fully exited CATALENT, INC. in Q4 2024, selling an estimated $31.8M.
  • Caxton Associates (New York)'s ten largest holdings make up 63% of its $3.18B portfolio in Q4 2024.
  • Caxton Associates (New York) opened 199 new positions and closed 234 in Q4 2024.
  • Caxton Associates (New York)'s portfolio value rose 19% quarter-over-quarter to $3.18B.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.